340B Covered Entity Security Risk Assessment Guide: Step-by-Step Checklist for Compliance

Understanding 340B Program Compliance

This guide helps you run a 340B covered entity program that is compliant, auditable, and secure. It connects day-to-day 340B operations with HIPAA security risk analysis so you can protect electronic protected health information (ePHI) while meeting program rules.

Core obligations you must operationalize

• Patient eligibility criteria: dispense or administer 340B drugs only to eligible patients of the covered entity, supported by encounter and prescriber documentation.
• Diversion prevention: ensure drugs purchased at 340B prices are used only for eligible outpatient use and registered locations.
• Medicaid duplicate-discount controls: coordinate carve-in/carve-out and claim identification to prevent duplicate discounts.
• Contract pharmacy oversight: monitor third-party arrangements, accumulators, replenishment, and claim edits for compliance.
• Compliance monitoring: use ongoing audits, exception queues, and KPI dashboards to detect and correct issues.
• Security risk analysis: safeguard ePHI across EHRs, TPAs, and contract pharmacy systems that power your 340B program.

Risk lens for leaders

Think of compliance as a control system: policy defines intent, workflows execute steps, technology enforces rules, and monitoring verifies results. Your security risk assessment validates that ePHI supporting eligibility and claims is protected end to end.

Conducting Patient Eligibility Verification

Eligibility is the foundation of your 340B program. Build it into clinical and pharmacy workflows so compliant decisions happen automatically, with clear documentation when exceptions occur.

Step-by-step checklist

1. Define patient eligibility criteria in policy, referencing your service lines, registered sites, and prescriber relationships.
2. Maintain a prescriber file that captures employment/contract status, credentials, and site affiliation; reconcile it monthly with HR and medical staff data.
3. Limit dispensing/administration to registered outpatient locations; use location codes to prevent use from unregistered sites.
4. Validate outpatient status at time of order/administration; exclude inpatient, observation-to-inpatient, and discharge supplies if your policy requires.
5. Confirm that the medical record for the encounter is maintained by the covered entity; do not rely on a pharmacy profile alone.
6. Link the prescription or order to a documented, billable clinical encounter for the same patient and condition when required by policy.
7. Integrate your EHR with the 340B accumulator so eligibility checks and prescriber/site validation run in real time.
8. Route mismatches (e.g., missing encounter, non-eligible site) to an exception queue; document root cause and final disposition.
9. Retain encounter, prescriber, and location evidence for each 340B claim per your record retention policy.
10. Monitor a monthly sample of claims for false positives/negatives and update rules accordingly.

Special scenarios to govern

• Telehealth and cross-coverage: ensure the prescriber relationship and encounter documentation still meet patient eligibility criteria.
• Residents, locum tenens, and contracted providers: verify employment/arrangement documentation and supervising relationships as applicable.
• Mixed-use settings: separate inpatient from outpatient utilization with charge capture, unit-of-use controls, and split-billing rules.
• Transitions of care: define what is eligible at discharge and how you will document clinical responsibility.

Medicaid duplicate-discount controls

• Declare carve-in or carve-out consistently and keep identifiers current across billing systems and state expectations.
• Apply state-specific claim identifiers or modifiers for 340B when required; validate that contract pharmacies follow the same controls.
• Reconcile Medicaid paid claims against your 340B accumulators to verify no duplicate discounts occurred; issue refunds promptly if needed.

Implementing HIPAA Security Risk Assessment

A security risk analysis anchors your obligation to protect ePHI used in 340B eligibility, accumulators, and contract pharmacy oversight. Treat it as a living program, not a one-time project.

Security risk analysis: step-by-step

1. Establish scope: include EHR, split-billing, TPA portals, SFTP feeds, contract pharmacy systems, analytics tools, and mobile workflows.
2. Inventory ePHI: map data elements, where they reside, who accesses them, and how they flow between systems.
3. Identify threats and vulnerabilities: unauthorized access, misconfigurations, weak authentication, vendor risks, and data leakage.
4. Analyze likelihood and impact: rate each risk to prioritize remediation; document assumptions and evidence.
5. Select safeguards: administrative (policies, BAAs, workforce training), physical (facility security), and technical (MFA, encryption, RBAC, audit logs).
6. Create a remediation plan: assign owners, budgets, and deadlines; track progress with risk registers and change tickets.
7. Implement monitoring: enable alerting for privileged access, failed logins, abnormal data movement, and API activity.
8. Test and validate: perform access recertification, backup/restoration drills, and incident response tabletop exercises.
9. Document thoroughly: retain the risk analysis, decisions, and evidence of implemented controls for audit readiness.
10. Review periodically and upon major changes: new TPAs, contract pharmacy expansions, or EHR upgrades.

Practical controls for 340B operations

• Least-privilege access to accumulators and claims; quarterly access reviews and immediate termination upon role changes.
• Encrypt ePHI in transit and at rest; restrict exports and require business justification for ad hoc data pulls.
• Vendor management: execute BAAs, review SOC reports, validate data segregation, and define breach notification timelines.
• Secure file exchange: use SFTP with key-based authentication and lifecycle policies for file retention and deletion.
• Logging and audit: capture user, system, and API events; retain logs to support HRSA audits and incident investigations.

Performing Compliance Culture Self-Assessment

Your culture determines whether policies work when no one is watching. Use a structured self-assessment to measure maturity and close gaps.

Self-assessment framework

1. Governance: board and executive oversight; defined accountability for 340B and HIPAA leadership roles.
2. Policies and standards: current, accessible, and mapped to workflows for eligibility, Medicaid duplicate-discount controls, and contract pharmacy oversight.
3. Training and competency: role-based, annual refreshers, and testing for high-risk functions.
4. Reporting and speak-up: confidential channels, non-retaliation, and rapid escalation of suspected noncompliance.
5. Monitoring and internal audits: defined plan, sampling methodology, and remediation tracking.
6. Enforcement and incentives: consistent discipline for violations and recognition for proactive risk reduction.
7. Response and prevention: root-cause analysis, corrective action plans, and effectiveness checks.

Maturity cues

• Ad hoc: reactive fixes, undocumented decisions.
• Developing: policies exist; monitoring is periodic and manual.
• Managed: KPIs, dashboards, and issue tracking are routine.
• Optimized: predictive analytics, automation, and continuous improvement embedded in operations.

Utilizing Hospital and Clinic Self-Assessment Checklists

Use tailored checklists to confirm that documentation, workflows, and controls are complete before issues surface in HRSA audits.

Hospital checklist

• Entity and site eligibility: verify registrations for parent and child sites; align location codes in the EHR and billing systems.
• Provider roster: employment/contract status and privileges; reconcile to scheduling and encounter data.
• Mixed-use and split-billing: accurate charge capture, unit-of-use mapping, and accumulator rules that exclude inpatient inventory.
• Contract pharmacy oversight: documented selection criteria, replenishment model controls, dispensing validation, and independent audits.
• Medicaid coordination: claim identification rules, state-specific requirements, and reconciliation proof.
• Compliance monitoring: monthly internal claim audits, issue logs, and corrective actions with due dates and owners.

Clinic checklist (FQHCs, CHCs, RHCs)

• Scope and sites: confirm each clinic’s registration and that orders originate from eligible locations.
• Encounter linkage: verify that each prescription is tied to a documented clinic visit with the clinic as the record of care.
• Prescriber alignment: maintain current lists of employed/contracted providers and supervising relationships where applicable.
• Contract pharmacy oversight: test claim filters, manage accumulator exceptions, and review dispensing records for diversion risks.
• Data integrity: validate ePHI feeds to TPAs, reconcile counts, and resolve mismatches promptly.

Preparing for HRSA Audits

Audit readiness is a continuous process. Build an always-ready file so you can respond quickly and confidently to HRSA audits.

Pre-audit readiness kit

• Program binder: entity eligibility, site registrations, policies, and governance charters.
• Eligibility evidence: encounter documentation, prescriber rosters, and location mappings for sampled claims.
• Contract pharmacy files: agreements, oversight procedures, monitoring reports, and findings with remediation.
• Medicaid duplicate-discount controls: carve-in/carve-out documentation, claim identifiers, and reconciliation reports.
• Security artifacts: latest security risk analysis, risk register, remediation plans, and vendor due diligence.

Mock audits and sampling

• Run quarterly mock audits mirroring HRSA sampling; include contract pharmacies and high-risk service lines.
• Use root-cause analysis for each exception; implement and verify corrective actions.

Day-of-audit playbook

• Assign roles: primary spokesperson, document control, subject-matter experts, and note taker.
• Provide only requested records; track every document shared and question asked.
• Close with a recap of any real-time corrections and planned follow-ups.

Common findings to prevent

• Ineligible patient or location: strengthen encounter linkage and site validation.
• Contract pharmacy oversight gaps: require independent audits and reconcile replenishment to dispenses.
• Medicaid duplicate discounts: standardize claim identifiers and monthly reconciliations.
• Documentation insufficiency: implement retention schedules and evidence checklists for each claim.

Developing Policies and Training for Risk Management

Policies articulate expectations; training operationalizes them; monitoring proves they work. Tie all three to your risk register and compliance monitoring plan.

Policy portfolio

• Patient eligibility criteria and diversion prevention with clear workflows and responsibilities.
• Medicaid duplicate-discount controls covering declarations, claim identifiers, and reconciliation.
• Contract pharmacy oversight: selection, onboarding, monitoring, and termination criteria.
• Security risk analysis and incident response, including breach notification and evidence preservation.
• Data governance: ePHI retention, minimum necessary access, and data export restrictions.
• Corrective action and refund processes with timelines and escalation paths.

Training and competency

• Role-based curricula for pharmacy, revenue cycle, IT, compliance, and contract pharmacy partners.
• Annual refreshers plus just-in-time training for workflow or system changes.
• Competency checks: scenarios, job aids, and post-training audits to confirm behavior change.

Monitoring and metrics

• Key indicators: eligibility exception rate, contract pharmacy override rate, refund timeliness, and access review completion.
• Security KPIs: MFA coverage, patch cadence, unresolved critical risks, and log review frequency.
• Governance cadence: monthly operational reviews and quarterly executive summaries.

Implementation roadmap

1. First 30 days: confirm scope, owners, and current-state risks; stabilize eligibility and Medicaid controls.
2. Days 31–60: complete security risk analysis, finalize policies, and launch targeted training.
3. Days 61–90: run a mock HRSA audit, close high-priority gaps, and publish a compliance monitoring dashboard.

Conclusion

By integrating a rigorous security risk analysis with clear eligibility rules, duplicate-discount safeguards, contract pharmacy oversight, and continuous compliance monitoring, you create a resilient 340B program. Use the step-by-step checklists to standardize practice, document decisions, and demonstrate readiness for HRSA audits.

FAQs.

What is the purpose of a 340B security risk assessment?

Its purpose is to identify and reduce risks to ePHI and 340B operational data across EHRs, TPAs, and contract pharmacy systems. The assessment drives safeguards, documents decisions, and proves that your program protects data while supporting accurate eligibility, accumulators, and audit readiness.

How do covered entities verify patient eligibility under 340B?

They verify the prescriber relationship, registered site, outpatient status at time of service, and the existence of a covered-entity medical record for the encounter. Systems enforce these checks in real time, exceptions route to a queue for review, and evidence is retained with each claim.

What are the key steps in conducting a HIPAA security risk assessment?

Define scope, inventory ePHI, analyze threats and vulnerabilities, rate likelihood and impact, select safeguards, document a remediation plan, implement monitoring, and review routinely and after major changes. Each step should map to owners, timelines, and evidence for audits.

How can covered entities prepare for HRSA audits?

Maintain an always-ready file with eligibility evidence, contract pharmacy oversight records, Medicaid duplicate-discount controls, and your latest security risk analysis. Conduct mock audits, sample high-risk claims, remediate issues, and assign clear day-of-audit roles to manage requests and responses efficiently.